PHENOTYPIC ANALYSIS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE DEAMINATION IN PATIENTS TREATED WITH HIGH-DOSES AND CORRELATION WITH RESPONSE

被引:21
作者
KREIS, W
LESSER, M
BUDMAN, DR
ARLIN, Z
DEANGELIS, L
BASKIND, P
FELDMAN, EJ
AKERMAN, S
机构
[1] N SHORE UNIV HOSP,DEPT RES,MANHASSET,NY 11030
[2] CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021
[3] NEW YORK MED COLL,VALHALLA,NY 10595
[4] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
关键词
PHENOTYPIC ANALYSIS; 1-BETA-D-ARABINOFURANOSYLCYTOSINE; DEAMINATION; ARA-C;
D O I
10.1007/BF00686404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two phenotypes for I-B-D-arabinofuranosylcytosine (ara-C) deamination corresponding to a ratio of distribution for "slow" (ratio, less-than-or-equal-to 14) vs "fast" (ratio, > 14) deaminators of 70%:30%, have been determined on the basis of studies on plasma ratios of 1-B-D-arabinofuranosyluracil/ara-C (ara-U/ara-C) in 56 subjects treated with high-dose ara-C (3 g/m2 infused i. v. over 3 h). A positive correlation of age with the concentration of ara-U was observed. In a subgroup of 36 patients with leukemia, the ara-U/ara-C pattern was similar to that observed for all 56 subjects. In these leukemic patients, who were treated with combinations of ara-C plus other conventional agents, a tendency toward a positive response (complete response + partial response) was found for those showing low ara-U/ara-C ratios (slow deaminators). The phenotypic effect of deamination in acute leukemia needs to be evaluated prospectively.
引用
收藏
页码:126 / 130
页数:5
相关论文
共 31 条